Substitution of a borano (BH 3 - ) group for nonbridging oxygen in the phosphate backbone of DNA results in a new class of isoelectronic and isoionic DNA analogues. An effective chemical method of synthesis of oligodeoxynucleoside boranophosphates (BH 3 - −ODNs) on a solid phase has been developed via an H -phosphonate chain elongation approach followed by boronation. The boronation procedure involves the intermediate conversion of an H -phosphonate to a phosphite triester group by silylation and subsequent oxidation by a borane−amine complex. The efficiency of the boronation procedure to form BH 3 - −ODNs is close to that of iodine oxidation to form phosphodiester ODNs. Oligothymidine boranophosphates of different lengths up to 12-mer have been readily synthesized, purified by HPLC and/or PAGE methods, and characterized by NMR spectroscopy and MS spectrometry. In physiologically relevant buffers the dodecathymidine boranophosphate hybridized with complementary dodecadeoxyadenylate and exhibited a cooperative melting transition ( T m = 14 °C). Studies of substrate properties showed that BH 3 - −ODNs are readily 5‘-phosphorylated by T4 polynucleotide kinase. Boranophosphate analogues are much more resistant toward nuclease hydrolysis than phosphodiester ODNs, and more resistant to P 1 and S 1 nucleases and snake venom phosphodiesterase than phosphorothioate ODNs.
No takes yet. Share an insight, caveat, or question.
Sergueev et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: